Status:
UNKNOWN
QoL Between CIEDs With and Without Rate Adaptive Pacing
Lead Sponsor:
National Taiwan University Hospital Hsin-Chu Branch
Conditions:
Pacemaker DDD
Quality of Life
Eligibility:
All Genders
20-100 years
Phase:
NA
Brief Summary
Clinical implantable electronic devices, such as permanent pacemaker, implantable cardioverter defibrillator and cardiac resynchronization therapy are used in current daily practice for patients with ...
Eligibility Criteria
Inclusion
- sick sinus syndrome for permanent dual-chamber pacing
- pacemakers are implanted for ≥30 days with no complications.
Exclusion
- (1) patient or legal representative could not provide written informed consent
- (2) unwillingness or inability to return for follow-up visits or reason to believe that adherence to follow-up visits wound be irregular,
- (3) current or scheduled enrollment in other, conflicting studies,
- (4) concomitant disease or other medical condition likely to result in death within 6 months, and
Key Trial Info
Start Date :
February 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT04383392
Start Date
February 1 2016
End Date
December 1 2020
Last Update
May 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital Hsinchu Branch
Hsinchu, Taiwan